Histologic features in the urinary bladder wall affected from neurogenic overactivity -: A comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A

被引:124
作者
Comperat, Eva [1 ]
Reitz, Andre
Delcourt, Annick
Capron, Frederique
Denys, Pierre
Chartier-Kastler, Emmanuel
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, Serv Anat Pathol, F-75013 Paris, France
[2] Univ Paris 06, Hop La Pitie Salpetriere, Urol Serv, F-75013 Paris, France
[3] Univ Paris Ile France Ouest, Hop Raymond Poincare, AP, Serv Med Phys & Readaptat, Paris, France
关键词
neurogenic bladder; botulinum toxin; inflammation; fibrosis; oedema; SPINAL-CORD-INJURY; STRUCTURAL BASIS; DETRUSOR HYPERREFLEXIA; DYSFUNCTION; INCONTINENCE; SUCCESS; MUSCLE;
D O I
10.1016/j.eururo.2006.01.025
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study histological features and morphological differences in bladder wall specimen from patients with and without botulinum toxin A injections and to compare those issues in responders and non-responders to the toxin therapy. Material and methods: Bladder wall specimen obtained from cystectomy in 45 patients with neurogenic overactive bladders with and without injection of botulinum toxin A into the detrusor muscle for treatment of neurogenic incontinence were evaluated concerning the histological criteria inflammation, oedema and fibrosis of the bladder wall. Results: Bladder wall specimen obtained from patients suffering from neurogenic detrusor overactivity showed important histological alterations. Generally, inflammatory infiltration, oedema and fibrosis of the bladder wall were frequently observed. When comparing specimen from patients who had received botulinum toxin injection to those from patients who had not, there was no difference concerning inflammation and oedema. However, patients who had received botulinum toxin injection showed significantly less fibrosis of the bladder wall than those who had not received the toxin injection (p < 0.00073). When comparing specimen from responders and non-responders to the botulinum. toxin therapy there was no difference in inflammation. Although not significant, a trend was observed that responder to the toxin therapy had less fibrosis and oedema of the bladder wall than non-responder. Conclusion: in our study injection of botulinum toxin into the detrusor muscle did not lead to increased fibrotic activity within the bladder wall, on the contrary patients with previous botulinum toxin injection revealed significant less fibrosis than patients without toxin injection. (c) 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1058 / 1064
页数:7
相关论文
共 19 条
[11]   Collagen directly stimulates bladder smooth muscle cell growth in vitro: Regulation by extracellular regulated mitogen activated protein kinase [J].
Herz, DB ;
Aitken, K ;
Bagli, DJ .
JOURNAL OF UROLOGY, 2003, 170 (05) :2072-2076
[12]  
KARSENTY G, 2005, ANN M INT C SOC MONT, pA242
[13]  
Macarak EJ, 1997, SCAND J UROL NEPHROL, V31, P25
[14]   28-K IN SQUAMOUS METAPLASIA OF THE BLADDER IN PATIENTS WITH SPINAL-CORD INJURY [J].
MONTGOMERIE, JZ ;
HOLSHUH, HJ ;
KEYSER, AJ ;
BENNETT, CJ ;
SCHICK, DG .
PARAPLEGIA, 1993, 31 (02) :105-110
[15]   European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity [J].
Reitz, A ;
Stöhrer, M ;
Kramer, G ;
Del Popolo, G ;
Chartier-Kastler, E ;
Pannek, J ;
Burgdörfer, H ;
Göcking, K ;
Madersbacher, H ;
Schumacher, S ;
Richter, R ;
von Tobel, J ;
Schurch, B .
EUROPEAN UROLOGY, 2004, 45 (04) :510-515
[16]   Bladder epithelium is abnormal in patients with neurogenic bladder due to myelomeningocele [J].
Schlager, TA ;
Grady, R ;
Mills, SE ;
Hendley, JO .
SPINAL CORD, 2004, 42 (03) :163-168
[17]   Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients:: A new alternative to anticholinergic drugs?: Preliminary results [J].
Schurch, B ;
Stöhrer, M ;
Kramer, G ;
Schmid, DM ;
Gaul, G ;
Hauri, D .
JOURNAL OF UROLOGY, 2000, 164 (03) :692-697
[18]   Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence:: Results of a single treatment, randomized, placebo controlled 6-month study [J].
Schurch, B ;
De Sèze, M ;
Denys, P ;
Chartier-Kastler, E ;
Haab, F ;
Everaert, K ;
Plante, P ;
Perrouin-Verbe, B ;
Kumar, C ;
Fraczek, S ;
Brin, MF .
JOURNAL OF UROLOGY, 2005, 174 (01) :196-200
[19]  
Simpson LL, 1971, NEUROPOISONS THEIR P, P303